In patients with NAFLD, increases in ALT and AST by more than 2–5 times the normal limit and an AST/ALT ratio < 1 have consistently been reported, possibly due to the effect of hepatocyte damage (23, 28). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.